Cited by 899Cancer-related Molecular PathwaysHeat shock proteins researchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Open access

Kamijo, Takehiko, Weber, Jason D., Zambetti, Gerard, Zindy, Frederique, Roussel, Martine F., Sherr, Charles J.·1998·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.95.14.8292PMC PMC20969

Open this paper in CoChat — free account

Abstract

The INK4a-ARF locus encodes two proteins, p16(INK4a) and p19(ARF), that restrain cell growth by affecting the functions of the retinoblastoma protein and p53, respectively. Disruption of this locus by deletions or point mutations is a common event in human cancer, perhaps second only to the loss of p53. Using insect cells infected with baculovirus vectors and NIH 3T3 fibroblasts infected with ARF retrovirus, we determined that mouse p19(ARF) can interact directly with p53, as well as with the p53 regulator mdm2. ARF can bind p53-DNA complexes, and it depends upon functional p53 to transcriptionally induce mdm2 and the cyclin-dependent kinase inhibitor p21(Cip1), and to arrest cell proliferation. Binding of p19(ARF) to p53 requires the ARF N-terminal domain (amino acids 1-62) that is necessary and sufficient to induce cell cycle arrest. Overexpression of p19(ARF) in wild type or ARF-null mouse embryo fibroblasts increases the half-life of p53 from 15 to approximately 75 min, correlating with an increased p53-dependent transcriptional response and growth arrest. Surprisingly, when overexpressed at supra-physiologic levels after introduction into ARF-null NIH 3T3 cells or mouse embryo fibroblasts, the p53 protein is handicapped in inducing this checkpoint response. In this setting, reintroduction of p19(ARF) restores p53's ability to induce p21(Cip1) and mdm2, implying that, in addition to stabilizing p53, ARF modulates p53-dependent function through an additional mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.95.14.8292

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Self-citation
QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES
Todaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,747
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100

Flagged first, then by citations

Show all 61 references

Research works printed but not linked: 10

M Hollstein, K Rice, M S Greenblatt, T Soussi, R Fuchs, T Sorlie, E Hovig, B Smith-Sorensen, R Montesano, C C Harris Nucleic Acids Res 22, 3551–3555 (1994).
D Duro, O Bernard, V Della Valle, R Berger, C-J Larsen Oncogene 11, 21–29 (1995).
L Mao, A Merlo, G Bedi, G I Shapiro, C D Edwards, B J Rollins, D Sidransky Cancer Res 55, 2995–2997 (1995).
S Stone, P Jiang, P Dayananth, S V Tavtigian, H Katcher, D Parry, G Peters, A Kamb Cancer Res 55, 2988–2994 (1995).
10.1128/mcb.13.7.4107-4114.1993 · DOI
P W Hinds, C A Finlay, R S Quartin, S J Baker, E R Fearon, B Vogelstein, A J Levine Cell Growth Diff 1, 571–580 (1990).
10.1128/mcb.7.8.2745-2752.1987 · DOI
10.1126/science.256.5058.827 · DOI
10.1128/mcb.2.9.1044-1051.1982 · DOI
G Shaulsky, N Goldfinger, M S Tosky, A J Levine, V Rotter Oncogene 6, 2055–2065 (1991).

Sorted by citations

Items 401–500 of 896

p53 dephosphorylation and p21Cip1/Waf1 translocation correlate with caspase-3 activation in TGF-β1-induced apoptosis of HuH-7 cells
Fan, G., Ma, X., Wong, P., Rodrigues, C. M. P., & Steer, C. J. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000018803.11260.02 · Cited by 45
ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 47
ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF
Datta, A., Sen, J., Hagen, J., Korgaonkar, C. K., Caffrey, M. S., Quelle, D. E., Hughes, D. E., Ackerson, T. J., Costa, R. H., & Raychaudhuri, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8024-8036.2005 · Cited by 46
Function and dysfunction of the human oncoprotein MDM2
Deb, S. P. (2002) · Frontiers in bioscience · doi:10.2741/a723 · Cited by 45
How to become immortal: let MEFs count the ways
Odell, A. F., Askham, J. M., Whibley, C., & Hollstein, M. (2010) · Aging · doi:10.18632/aging.100129 · Cited by 44
Induction of apoptosis in cancer: new therapeutic opportunities
Ding, H., & Fisher, D. E. (2002) · Annals of Medicine · doi:10.1080/078538902321012405 · Cited by 44
The evolution of Sex-linked barring alleles in chickens involves both regulatory and coding changes in CDKN2A
Schwochow, D., Ring, H., Sundström, E., Cao, X., Larsson, M., Kerje, S., Höglund, A., Fogelholm, J., Wright, D., Jemth, P., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006665 · Cited by 44
Hyperproliferation and p53 Status of Lens Epithelial Cells Derived from αB-crystallin Knockout Mice
Bai, F., Xi, J. H., Wawrousek, E. F., Fleming, T. P., & Andley, U. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304010200 · Cited by 44
Molecular biology of gliomas
Lassman, A. B. (2004) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-004-0043-3 · Cited by 44
Role of Retinoblastoma Tumor Suppressor Protein in DNA Damage Response
Wang, S. N. J. Y. J. (2001) · Acta Oncologica · doi:10.1080/02841860152619098 · Cited by 42
Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway*
Sugihara, T., Kaul, S. C., Kato, J., Reddel, R. R., Nomura, H., & Wadhwa, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100011200 · Cited by 44
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
Damasio, M. P. S., Nascimento, C. S., de Andrade, L. M., de Oliveira, V. L., & Calzavara-Silva, C. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1021609 · Cited by 46
Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
Taneja, P., Zhu, S., Maglic, D., Fry, E. A., Kendig, R. D., & Inoue, K. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7516 · Cited by 44
Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis
Schuster, K., Venkateswaran, N., Rabellino, A., Girard, L., Peña‐Llopis, S., & Scaglioni, P. P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0620-t · Cited by 43
p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts
Khan, S. H., Guevara, C. I., Fujii, G., & Parry, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207824 · Cited by 41
ARF mutation accelerates pituitary tumor development in Rb +/− mice
Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Nikitin, A. Y., Bronson, R. T., Mercer, K. L., Crowley, D. G., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262499599 · Cited by 43
Functional and Physical Interaction of the Human ARF Tumor Suppressor with Tat-binding Protein-1
Pollice, A., Nasti, V., Ronca, R., Vivo, M., Iacono, M. L., Calogero, R., Calabrò, V., & Mantia, G. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310957200 · Cited by 46
Regulated nuclear localization of stress-responsive factors: how the nuclear trafficking of protein kinases and transcription factors contributes to cell survival
Ferrigno, P. K., & Silver, P. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203132 · Cited by 43
Conserved RB functions in development and tumor suppression
Gordon, G. M., & Du, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1117-z · Cited by 45
Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
Fairlie, W. D., & Lee, E. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062841 · Cited by 45
Nfkb1 is dispensable for Myc-induced lymphomagenesis
Keller, U. B., Nilsson, J. A., Maclean, K. H., Old, J. B., & Cleveland, J. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208779 · Cited by 42
Evaluation of an Indicator for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma Invading the Submucosal Layer
Nakajima, Y., Nagai, K., Miyaké, S., Ohashi, K., Kawano, T., & Iwai, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02173.x · Cited by 42
An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer
Suga, S., Kato, K., Ohgami, T., Yamayoshi, A., Adachi, S., Asanoma, K., Yamaguchi, S., Arima, T., Kinoshita, K., & Wake, N. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.12.030 · Cited by 41
Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs
Wang, H., Qian, H., Yu, J., Zhang, X., Zhang, L., Fu, M., Liang, X., Zhan, Q., & Chen, L. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.4.2477 · Cited by 41
Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5
Tago, K., Funakoshi‐Tago, M., Itoh, H., Furukawa, Y., Kikuchi, J., Kato, T., Suzuki, K., & Yanagisawa, K. (2014) · Oncogene · doi:10.1038/onc.2013.561 · Cited by 41
Cellular senescence in tissue repair: every cloud has a silver lining
Yun, M. H. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180081my · Cited by 44
Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis
Zeini, M., Través, P. G., López-Fontal, R., Pantoja, C., Matheu, A., Serrano, M., Boscá, L., & Hortelano, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3327 · Cited by 40
The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis
Herkert, B., Dwertmann, A., Herold, S., Abed, M., Naud, J., Finkernagel, F., Harms, G. S., Orian, A., Wanzel, M., & Eilers, M. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200908103 · Cited by 40
Update on genetic events in the pathogenesis of melanoma
Halachmi, S., & Gilchrest, B. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200103000-00008 · Cited by 41
Analysis of JNK, Mdm2 and p14ARF contribution to the regulation of mutant p53 stability
Buschmann, T., Minamoto, T., Wagle, N., Fuchs, S. Y., Adler, V., Mai, M., & Ronai, Z. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3387 · Cited by 41
Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope Tumor
Wood, W. M., Sarapura, V. D., Dowding, J. M., Woodmansee, W. W., Haakinson, D. J., Gordon, D. F., & Ridgway, E. C. (2002) · Endocrinology · doi:10.1210/en.143.2.347 · Cited by 41
Molecular targeted therapies in metastatic melanoma
Comfere, N. I., Chakraborty, & Wieland, W. (2013) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s44800 · Cited by 41
Anatomy of Mdm2 and Mdm4 in evolution
Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40
CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation
Zhang, P., Gao, K., Zhang, L., Sun, H., Zhao, X., Liu, Y., Lv, Z., Shi, Q., Chen, Y., Jiao, D., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00890-0 · Cited by 39
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 42
Dual effects of hepatitis C virus Core protein on the transcription of cyclin‐dependent kinase inhibitor p21 gene
Kwun, H. J., & Jang, K. L. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00434.x · Cited by 40
Pathological investigation of oxidative stress in the post‐genomic era
Toyokuni, S., & Akatsuka, S. (2007) · Pathology International · doi:10.1111/j.1440-1827.2007.02127.x · Cited by 40
Regulation of Apoptosis During Mammary Involution by the p53 Tumor Suppressor Gene
Jerry, D. J., Dickinson, E. S., Roberts, A. L., & Said, T. K. (2002) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(02)74171-4 · Cited by 40
Identification of a CK2 phosphorylation site in mdm2.
Götz, C., Kartarius, S., Scholtes, P., Nastainczyk, W., & Montenarh, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00882.x · Cited by 39
p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
Zeng, Y., Kotake, Y., Pei, X., Smith, M. D., & Xiong, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3483 · Cited by 41
Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
Kabir, F. M. L., Alvarez, C. E., & Bird, R. (2015) · Veterinary Sciences · doi:10.3390/vetsci3010001 · Cited by 44
Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2
Clark, P. A., Llanos, S., & Peters, G. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205558 · Cited by 39
Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner
Boutell, C., & Everett, R. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8068-8077.2004 · Cited by 42
Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway
Lv, H., Liu, R., Fu, J., Yang, Q., Shi, J., Chen, P., Ji, M., Shi, B., & Hou, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947203 · Cited by 39
Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells
Horvat, A., Noto, J. M., Ramatchandirin, B., Zaika, E. I., Palrasu, M., Wei, J., Schneider, B., El-Rifai, W. M., Peek, R. M., & Zaika, A. I. (2018) · Oncogene · doi:10.1038/s41388-018-0343-8 · Cited by 40
SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase–p53–Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo
Sukumar, U. K., Rajendran, J. C. B., Gambhir, S. S., Massoud, T. F., & Paulmurugan, R. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b20071 · Cited by 38
ATM activity contributes to the tumor-suppressing functions of p14ARF
Li, Y., Wu, D., Chen, B., Ingram, A. J., He, L., Liu, L., Zhu, D., Kapoor, A., & Tang, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207957 · Cited by 37
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Nieto‐Sampedro, M., Valle‐Argos, B., Gómez‐Nicola, D., Fernández‐Mayoralas, A., & Nieto‐Díaz, M. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7685 · Cited by 39
Simulation-Based Validation of the p53 Transcriptional Activity with Hybrid Functional Petri Net
Doi, A., Nagasaki, M., Matsuno, H., & Miyano, S. (2006) · In Silico Biology · doi:10.3233/isb-00216 · Cited by 39
Proapoptotic p53-Interacting Protein 53BP2 Is Induced by UV Irradiation but Suppressed by p53
Lopez, C. D., Ao, Y., Rohde, L. H., Perez, T. D., O’Connor, D. J., Lü, X., Ford, J. M., & Naumovski, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8018-8025.2000 · Cited by 38
ARF Tumor Suppressor Induces Mitochondria-dependent Apoptosis by Modulation of Mitochondrial Bcl-2 Family Proteins
Nakazawa, Y., Kamijo, T., Koike, K., & Noda, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300510200 · Cited by 38
Self-citation
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates
Simpson, L., & Galanis, E. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.11.1593 · Cited by 38
P16INK4A is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation
Chazal, M., Marionnet, C., Michel, L., Mollier, K., Dazard, J.-E., Della-Valle, V., Larsen, C., Gras, M.-P., & Basset‐Séguin, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205349 · Cited by 39
Melanoma Genetics: An Update on Risk-Associated Genes
Udayakumar, D., & Tsao, H. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.03.011 · Cited by 39
Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53
Valente, L. J., Grabow, S., Vandenberg, C. J., Strasser, A., & Janic, A. (2015) · Oncogene · doi:10.1038/onc.2015.457 · Cited by 37
Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A
Kumazawa, T., Nishimura, K., Katagiri, N., Hashimoto, S., Hayashi, Y., & Kimura, K. (2015) · Scientific Reports · doi:10.1038/srep10854 · Cited by 38
The Nucleolar Protein Myb-binding Protein 1A (MYBBP1A) Enhances p53 Tetramerization and Acetylation in Response to Nucleolar Disruption
Ono, W., Hayashi, Y., Yokoyama, W., Kuroda, T., Kishimoto, H., Ito, I., Kimura, K., Akaogi, K., Waku, T., & Yanagisawa, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474049 · Cited by 39
Expression of p14, MDM2, and MDM4 in human retinoblastoma
Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 36
The Cellular Decision Between Apoptosis and Autophagy
Fan, Y., Ullman, E., & Zong, W. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-9 · Cited by 37
Role for PP2A in ARF signaling to p53
Moule, M. G., Collins, C. H., McCormick, F. P., & Fried, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405533101 · Cited by 37
Alterations of the INK4a/ARF locus in human intracranial germ cell tumors.
Iwato, M., Tachibana, O., Tohma, Y., Arakawa, Y., Nitta, H., Hasegawa, M., Yamashita, J., & Hayashi, Y. (2000) · PubMed · Cited by 36
Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
Shahnavaz, S. A., Bradley, G., Regezi, J. A., Thakker, N., Gao, L., Hogg, D., & Jordan, R. C. (2001) · PubMed · Cited by 37
Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
Nambiar, P. R., Giardina, C. A., Guda, K., Aizu, W., Raja, R. G., & Rosenberg, D. W. (2002) · PubMed · Cited by 37
Inhibition of v-Abl transformation by p53 and p19ARF
Cong, F., Zou, X., Hinrichs, K., Calame, K. L., & Goff, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203290 · Cited by 38
E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation
Nip, J., Strom, D. K., Eischen, C. M., Cleveland, J. L., Zambetti, G. P., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204171 · Cited by 37
Self-citation
p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts
Kurokawa, K., Tanaka, T., & Kato, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202628 · Cited by 37
Autophagy in toxicology: self‐consumption in times of stress and plenty
Bolt, A. M., & Klimecki, W. T. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.1787 · Cited by 36
Splicing Up Mdm2 for Cancer Proteome Diversity
Okoro, D. R., Rosso, M., & Bargonetti, J. (2012) · Genes & Cancer · doi:10.1177/1947601912455323 · Cited by 36
A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells
Li, X., Wang, X., Wang, X., Liu, S.-H., Ding, X., Chen, G., & Lu, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737056 · Cited by 36
Negative auto-regulators trap p53 in their web
Zhou, X. Y., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 37
Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity
Moussa, R., Park, K. C., Kovačević, Ž., & Richardson, D. R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.027 · Cited by 39
Contribution of Estrogen Receptor α to Oncogenic K-Ras-mediated NIH3T3 Cell Transformation and Its Implication for Escape from Senescence by Modulating the p53 Pathway
Kato, K., Horiuchi, S., Takahashi, A., Ueoka, Y., Arima, T., Matsuda, T., Kato, H., Nishida, J.-I., Nakabeppu, Y., & Wake, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107391200 · Cited by 36
The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame ( INK4a/ARF ) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Distinct cis Elements
D’Amico, M., Wu, K., Fu, M., Rao, M., Albanese, C., Russell, R. G., Lian, H., Bregman, D. B., White, M. A., & Pestell, R. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2519 · Cited by 38
Dynamics of ARF regulation that control senescence and cancer
Ko, A., Han, S. Y., & Song, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.120 · Cited by 35
KDM5A Regulates a Translational Program that Controls p53 Protein Expression
Hu, D., Jablonowski, C. M., Cheng, P.-H., AlTahan, A. M., Li, C., Wang, Y., Palmer, L. E., Lan, C., Sun, B., Abu‐Zaid, A., et al. (2018) · iScience · doi:10.1016/j.isci.2018.10.012 · Cited by 34
Self-citation
p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
Chahat, Bhatia, R., & Kumar, B. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115020 · Cited by 37
Harmonic Oscillations in Homeostatic Controllers: Dynamics of the p53 Regulatory System
Jolma, I. W., Ni, X. Y., Rensing, L., & Ruoff, P. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.11.013 · Cited by 35
MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts
Gentiletti, F., Mancini, F., D'Angelo, M., Sacchi, A., Pontecorvi, A., Jochemsen, A. G., & Moretti, F. (2002) · Oncogene · doi:10.1038/sj.onc.1205137 · Cited by 36
Essential Role of Phospholipase Cγ2 in Early B-Cell Development and Myc-Mediated Lymphomagenesis
Wen, R., Chen, Y., Bai, L., Fu, G., Schuman, J., Dai, X., Zeng, H., Yang, C., Stephan, R. P., Cleveland, J. L., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00839-06 · Cited by 34
The genetics of malignant melanoma
Lomas, J. (2008) · Frontiers in bioscience · doi:10.2741/3065 · Cited by 34
ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4
Dominguez‐Brauer, C., Chen, Y., Brauer, P. M., Pimkina, J. S., & Raychaudhuri, P. (2009) · EMBO Reports · doi:10.1038/embor.2009.139 · Cited by 34
The Cell Cycle: Accelerators, Brakes, and Checkpoints
Ivanchuk, S. M., & Rutka, J. T. (2004) · Neurosurgery · doi:10.1227/01.neu.0000109534.28063.5d · Cited by 33
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
Jackson, M. W., Agarwal, M. K., Agarwal, M. L., Agarwal, A. M., Stanhope-Baker, P., Williams, B. R. G., & Stark, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207575 · Cited by 33
Disruption of the Cockayne Syndrome B Gene Impairs Spontaneous Tumorigenesis in Cancer-Predisposed Ink4a/ARF Knockout Mice
Lu, Y., Lian, H., Sharma, P., Schreiber‐Agus, N., Russell, R. G., Chin, L., van der Horst, G. T. J., & Bregman, D. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1810-1818.2001 · Cited by 34
Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts
Alunni‐Fabbroni, M., Littlewood, T. D., Deleu, L., Caldeira, S., Giarrè, M., Orco, M. D., & Tommasino, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203570 · Cited by 34
Evaluation of Methods to Detect p53 Mutations in Ovarian Cancer
Meinhold-Heerlein, I. M., Ninci, E., Ikenberg, H., Brandstëtter, T., Ihling, C. H., Schwenk, I., Straub, A., Schmitt, B., Bettendorf, H., Iggo, R. D., et al. (2001) · Oncology · doi:10.1159/000055316 · Cited by 34
Wild-type and Hupki (Human p53 Knock-in) Murine Embryonic Fibroblasts
Whibley, C. E., Odell, A. F., Nedelko, T., Balaburski, G. M., Murphy, M. E., Liu, Z., Stevens, L., Walker, J. H., Routledge, M. N., & Hollstein, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064444 · Cited by 33
Genetic Determinants of Cutaneous Melanoma Predisposition
Udayakumar, D., Mahato, B., Gabree, M., & Tsao, H. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.06.002 · Cited by 34
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
Koss, B. S., Shields, B. D., Taylor, E. M., Storey, A. J., Byrum, S. D., Gies, A. J., Washam, C. L., Choudhury, S. R., Ahn, J. H., Uryu, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0524 · Cited by 33
Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development
Eischen, C. M., Alt, J. R., & Wang, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208052 · Cited by 32
Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization
Kim, C. K., Lee, S. B., Nguyen, T. L. X., Lee, K.-H., Um, S. H., Kim, J., & Ahn, J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.013 · Cited by 32
Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF
Han, S. Y., Ko, A., Kitano, H., Choi, C. H., Lee, M.-S., Seo, J., Fukuoka, J., Kim, S., Hewitt, S. M., Chung, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0613 · Cited by 33
Physical and Functional Interaction between Ribosomal Protein L11 and the Tumor Suppressor ARF
Dai, M., Challagundla, K. B., Sun, X., Palam, L. R., Zeng, S. X., Wek, R. C., & Lu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311902 · Cited by 31
Genetics of melanoma
Wangari‐Talbot, J., & Chen, S. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00330 · Cited by 34
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T‐cell acute lymphoblastic leukaemia
Woerden, N. L. R.-V., Pieters, R., Slater, R. M., Loonen, A. H., Beverloo, H. B., van Drunen, E., Heyman, M. M., Moreno, T. C., Rots, M. G., Wering, E. R., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02586.x · Cited by 32
Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway
Shamanin, V. A., & Androphy, E. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2144-2152.2004 · Cited by 32
MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis
Akaogi, K., Ono, W., Hayashi, Y., Kishimoto, H., & Yanagisawa, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-65 · Cited by 31
Expression of theArftumor suppressor gene is controlled by Tgfβ2 during development
Freeman-Anderson, N. E., Zheng, Y., McCalla-Martin, A. C., Treanor, L. M., Zhao, Y. D., Garfin, P. M., He, T., Mary, M. N., Thornton, J. D., Anderson, C., et al. (2009) · Development · doi:10.1242/dev.033548 · Cited by 34
DNA Hypermethylation Status of Multiple Genes in Papillary Thyroid Carcinomas
Ishida, E., Nakamura, M., Shimada, K., Higuchi, T., Takatsu, K., Yane, K., & Konishi, N. (2007) · Pathobiology · doi:10.1159/000110028 · Cited by 31
ZNF668 Functions as a Tumor Suppressor by Regulating p53 Stability and Function in Breast Cancer
Hu, R., Peng, G., Dai, H., Breuer, E.-K. Y., Stemke‐Hale, K., Li, K., Gonzalez-Angulo, A. M., Mills, G. B., & Lin, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0853 · Cited by 31

Authors: Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J.
Affiliations: St. Jude Children's Research Hospital (US)
Howard Hughes Medical Institute and Departments of Tumor Cell Biology and Biochemistry, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN 38105
Corresponding author: Sherr, Charles J.
ORCID: Kamijo, Takehiko
Weber, Jason D.
Zambetti, Gerard
Roussel, Martine F.
Sherr, Charles J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1998-07-07
Volume: 95
Issue: 14
Pages: 8292-8297
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.95.14.8292
PMC: PMC20969
OpenAlex: W2141529421
Cited by: 899
References: 61
Citations by year: 2026: 5 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 26 · 2015: 21 · 2014: 33 · 2013: 28 · 2012: 34
FWCI: 31.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Institutes of Health (CA21765))
National Cancer Institute (R01CA063230, CA-71907, CA-63230, CA21765, P30CA021765, P01CA071907)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: p19ARF, p53, MDM2, INK4a/ARF locus, p16INK4a, protein-protein interaction, p53 stabilization, p21 Cip1, cell cycle arrest, p53-dependent transcription, tumor suppressor, p53 DNA binding, N-terminal domain
MeSH terms: Animals, Humans, Neoplasm Proteins, Nuclear Proteins, Proteins, Proto-Oncogene Proteins, Retroviridae, Transfection, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, 3T3 Cells, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks